BioNexus Gene Lab Corp.
(BGLC) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
0.35
-5.41%
After-hours Jan 06, 2025, 07:56 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Cash & Equivalents | 5.93M | 2.12M | 2.12M | 2.79M | 859.08K | 1.26M | 839.14K | 26.00 |
Short-Term Investments | n/a | 1.51M | 1.55M | 2.09M | 493.04K | 601.00K | 2.55K | n/a |
Long-Term Investments | 1.70M | 1.15M | 749.03K | 281.67K | 12.21K | 12.08K | n/a | n/a |
Other Long-Term Assets | n/a | -2.72M | n/a | -2.13M | -348.67K | n/a | n/a | n/a |
Receivables | 857.26K | 2.90M | 3.36M | 4.00M | 15.91K | n/a | n/a | n/a |
Inventory | 1.14M | 977.81K | 1.52M | 1.18M | 7.58K | 15.30K | 32.09K | n/a |
Other Current Assets | 122.43K | n/a | 147.12K | n/a | n/a | 22.81K | 125.94K | n/a |
Total Current Assets | 8.05M | 6.02M | 7.15M | 7.99M | 882.57K | 1.30M | 999.72K | 26.00 |
Property-Plant & Equipment | 1.65M | 1.57M | 1.68M | 1.85M | 336.45K | 341.81K | 273.16K | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 3.35M | 2.72M | 2.42M | 2.13M | 348.67K | 353.88K | 273.16K | n/a |
Total Assets | 11.40M | 8.74M | 9.57M | 10.12M | 1.23M | 1.65M | 1.27M | 26.00 |
Account Payables | 1.40M | 1.86M | 2.01M | 3.17M | n/a | n/a | 35.09K | 1.34K |
Deferred Revenue | n/a | 23.12K | 107.58K | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 34.63K | 33.14K | 79.01K | 91.50K | 64.27K | 19.13K | n/a | n/a |
Other Current Liabilities | 194.11K | 86.80K | 32.31K | 50.13K | -12.70K | 11.15K | 1.14M | n/a |
Total Current Liabilities | 1.63M | 2.00M | 2.33M | 3.37M | 51.57K | 62.89K | 1.17M | 1.34K |
Long-Term Debt | 98.76K | 40.21K | 37.44K | 77.67K | 12.21K | 62.94K | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | 45.09K | n/a | n/a | n/a |
Total Long-Term Liabilities | 111.02K | 71.07K | 65.86K | 79.54K | 57.30K | 67.42K | 4.57K | n/a |
Total Liabilities | 1.74M | 2.08M | 2.39M | 3.45M | 108.87K | 130.31K | 1.18M | 1.34K |
Total Debt | 133.40K | 56.77K | 76.95K | 123.42K | 89.44K | 82.06K | n/a | n/a |
Common Stock | 17.19M | 10.93M | 10.78M | 10.78M | 6.48M | 6.65M | 5.21M | 1.00 |
Retained Earnings | -1.84M | 1.16M | 1.51M | 760.79K | -333.31K | -86.84K | -113.30K | -1.44K |
Comprehensive Income | -677.29K | -409.06K | -100.26K | 133.68K | -17.10K | -26.98K | 14.05K | 126.00 |
Shareholders Equity | 9.66M | 6.67M | 7.18M | 6.66M | 1.12M | 1.52M | 94.63K | -1.31K |
Total Investments | 1.70M | 1.15M | 749.03K | 281.67K | 12.21K | 12.08K | 2.55K | n/a |